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Summary Factors influencing time to loco-regional recurrence were identified in a multivariate regression
analysis of data from a series of 468 radically operated patients (260 Dukes' B and 208 Dukes' C) with
carcinoma of the rectum and the rectosigmoid. A number of clinical and pathological characteristics were
prospectively collected and recorded. In addition, carcinoembryonic antigen (CEA) was measured within I
week before surgery. The endpoint used was recurrence below the level of the umbilicus. All patients were
followed for at least 5 years or until time of death.
The two Dukes' stages B and C were analysed in two separate analyses using the Cox proportional hazards
model. In patients with Dukes' B tumours, an increased risk of loco-regional recurrence was associated with
perineural invasion, tumour located less than 10 cm from the anal verge, patient aged above 70 years, and
small tumour size. In patients with Dukes' C tumours, the necessity to resect neighbour organs, perineural and
venous invasion, tumour located less than 10 cm from the anal verge, and large tumour size were all associated
with a poor loco-regional outcome. Postoperative radiotherapy was not a significant prognosticator for
loco-regional control.
An update of the 5-year results of the randomised study of post-operative radiotherapy (50 Gy with 2 Gy
per fraction in an overall treatment time of 7 weeks) showed no survival benefit from adjuvant radiotherapy in
either Dukes' category and no statistically significant improvement in the 5-year loco-regional control rate.
However, when the comparison was restricted to a group of high-risk patients there was a statistically
significant benefit from radiotherapy with respect to loco-regional control (P = 0.03) but not with respect to
survival (P = 0.23). The potential advantage, in terms of the required number ofpatients, of restricting clinical
trials of intensified loco-regional therapies to the high-risk patients, is illustrated.
Loco-regional control remains a major problem among
patients with Dukes' B or C colorectal carcinoma even in
cases where surgery is judged to be radical. Several ran-
domised (Balslev et al., 1982; Gastrointestinal Tumor Study
Group, 1985; Fisher et al., 1988) or historically-controlled
clinical trials (Tepper et al., 1987; Vigliotti et al., 1987;
Mohiuddin et al., 1985) have been concerned with the poss-
ible benefit from adjuvant post-operative radiotherapy in this
disease. With respect to survival all have come out negative
(Bentzen et al., 1988a; Douglass et al., 1986; Fisher et al.,
1988): postoperative radiotherapy has not improved survival
significantly even when quite substantial numbers of patients
are compared. With respect to loco-regional control or
disease-free survival diverse conclusions have been reached:
in the NSABP study R-01 there was an overall reduction in
loco-regional recurrence from 25% to 16% (P = 0.06 (Fisher
et al., 1988)), while the GITSG study found no significant
reduction in the loco-regional recurrence rate after adjuvant
radiotherapy (Gastrointestinal Tumour Study Group, 1985).
One possible explanation is that the very large variability in
natural history of colorectal carcinoma (Bentzen et al.,
1988a), even within a specific Dukes' stage, might over-
shadow the possible benefit from adjuvant therapy (Tannock,
1989; Bentzen et al., 1988a). The present multivariate analysis
of clinico-pathological factors affecting the time to loco-
regional recurrence was undertaken in order to define high-
risk subpopulations of patients with Dukes' B and C
tumours. Furthermore, we discuss the potential gain from
restricting trials of therapies aimed at improving the loco-
regional control to these high risk patients.
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Methods and materials
A total of 494 patients were randomised in a multicenter
study (Balslev et al., 1982; Balslev et al., 1986; Bentzen et al.,
1988a) of the effect of postoperative adjuvant radiotherapy
after resection of Dukes' B and C colorectal cancer. The
study was open for patient intake from September 1979 to
March 1984 (Dukes' B) or March 1985 (Dukes' C). Staging
was performed according to Dukes' classification (Dukes &
Bussey, 1958), with B tumours defined as having penetrated
the bowel wall completely, and C tumours as having regional
lymph node metastases regardless of the degree of bowel-wall
penetration. Exclusion criteria were: tumour above the pelvis,
patients aged over 80 years, surgeryjudged to be non-radical,
patients bedridden more than 50% of the day 20-25 days
after surgery, post-operative complications, previous cancer
within 5 years, and previous radiotherapy. Details of the
study design and the results of the randomised trial have
previously been published (Balslev et al., 1982; Balslev et al.,
1986; Bentzen et al., 1988a; Kronborg et al., 1988).
Clinical, pathological and biochemical data, evaluated and
recorded prospectively, formed the basis for two separate
multivariate analyses (Bentzen et al., 1988a) of prognostic
factors in 260 patients with Dukes' B and 208 patients with
Dukes' C carcinoma of the rectum and the rectosigmoid who
had complete data records. Here, a similar analysis is pre-
sented using locoregional recurrence as the endpoint.
Postoperative radiotherapy
As a general rule, radiotherapy was started within 30 days
after surgery, but in patients with surgical complications this
period could be up till 60 days. The total target dose was
50 Gy given in 2 Gy per fraction, five fractions per week. A
split-course schedule was employed with a 2 week break after
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30 Gy. All patients were treated in the prone position with
8-16 MV photons using one posterior and two parallel
opposing lateral fields or with a four-field technique using
two parallel opposing lateral fields and two parallel opposing
anterior-posterior fields. All fields were treated in each treat-
ment session.
The target volume included the entire pelvis with the prox-
imal field limit at the mid-level of the 5th lumbar vertebra. In
patients having anterior or low anterior resection the distal
field limit was the lower margin of the obturator foramen,
whereas in patients having abdominoperineal resection the
field included the perineal region. Laterally, the pelvic brim
was included with a 1.5 to 2cm margin. The lateral fields
included the posterior surface of the symphysis and the entire
sacral cavity with proximal/distal field limits matching those
of the posterior field. The target volume was defined on
ordinary simulator radiographs and individually shaped
shielding blocks were made to encompass the target volume
with a 2 to 3 cm margin.
A detailed account of treatment-related complications have
been presented by Balslev et al. (1986).
transient prolongation of the time to loco-regional recurrence
in Dukes' C patients treated with adjuvant radiotherapy
(Figure 1). However, at about 2.5 years the two loco-regional
control curves cross. If all observations were censored at 1.5
years there appeared to be a highly significant advantage
from adjuvant radiotherapy, the P-value being less than
0.006 with both the Mantel-Cox and the Gehan-Breslow
tests. When censoring was done at 2 years the advantage was
borderline significant when using the Mantel-Cox test statis-
tics (v? = 3.01, P = 0.08) but still significant at the 5% level
when applying the Gehan-Breslow test (X2 = 4.84, P = 0.03).
At 5 years none of the two tests revealed a significant benefit
from radiotherapy.
The multivariate PHM analyses were restricted to those
patients having complete data records. Table II shows the
distribution of those patients characteristics that were found
to have statistical significance in describing the prognosis in
the two Dukes' stages. A number of clinico-pathological
characteristics were tested and the results are briefly present-
ed in the following.
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Statistical methods
Actuarial estimates of loco-regional control in subgroups of
patients was obtained by the product-limit method (Kaplan
& Meier, 1958). When comparing two groups only, the
Mantel-Cox log rank test (Mantel, 1966) or the Gehan-Bres-
low tests (Gehan, 1965) were used as univariate statistical test
for difference in control probability. The Gehan-Breslow test
weights observations at short times, where a higher number
of patients are still at risk, relatively more than the Mantel-
Cox test. In case of more than two groups a test-for-trend
(Tarone, 1975) based on the logrank test was used.
Multivariate regression analysis of time to loco-regional
recurrence in the two Dukes' stages was conducted using the
Cox' Proportional Hazards Model (PHM) (Cox, 1972).
Quantitation of the observed differences in loco-regional con-
trol rates was obtained by the ratio of hazard rates estimated
from the Cox PHM or, in the univariate case, by the Mantel-
Haentzel estimate (Crowley, 1975). The endpoint used in the
analyses was any recurrence below the level of the umbilicus.
All patients were followed for 5 years or until time of death.
Results
An update of the 5-year treatment results among all random-
ized patients is presented in Table I. In both Dukes' B and C
patients no statistically significant benefit from adjuvant
radiotherapy, as administered in the CRES study, could be
demonstrated with respect to either 5-year crude survival or
loco-regional control. In the Dukes' B group, the hazard rate
for loco-regional recurrence among patients treated with
surgery alone was estimated to be 1.14 (95% c.l. 0.64-2.0)
times as high as that of patients who received postoperative
radiotherapy. In the Dukes' C group the ratio of hazard
rates was 1.01 (95% c.l. 0.64-1.6). Thus the relative risk of
loco-regional recurrence was not significantly different from
one when comparing patients who did or did not receive
post-operative radiotherapy. There seemed, however, to be a
Table I Treatment results at 5 years (± 1 standard error of the
estimate) with and without adjuvant radiotherapy
No. of
ptsa Loco-regional control Crude survival
Dukes' B
surgery 139 82.1±34% P=.467.8+4.1 =04
surgery + RT 137 85.3± 3.2% P = 64.7±4.2%
Dukes' C
surgery 111 62.2+5-3% p = 0.89 27-3 +4-3% _ 0.47
surgery + RT 107 55.3±5.9% 36.8+4.7%
'All randomised patients.
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Figure 1 Loco-regional control vs observation time after resec-
tion for Dukes' B or C tumours with or without adjuvant radio-
therapy. Number of patients and estimated 5-year control prob-
abilities in the various groups are found in Table I.
TableII Patientcharacteristicsfor260patientswith Dukes' Band208
patients with Dukes' C colorectal cancer
Frequency (%)
Characteristics PHM score Dukes' B Dukes' C
Perineural invasion Yes 1 42 (16%) 79 (38%)
No 0 218 (84%) 129 (62%)
Venous invasion Yes 1 63 (24%) 65 (31%)
No 0 197 (76%) 143 (69%)
Resection of other Yes 1 29 (11%) 22 (11%)
organs No 0 231 (89%) 186 (89%)
Distance from anal < 10 1 87 (34%) 100 (48%)
verge (cm) > 10 0 173 (66%) 108 (52%)
Pre-operative CEA 0-3.1 0 147 (56%) 90 (43%)
(ngml-') 3.2-7.0 1 62 (24%) 46 (22%)
7.1 + 2 51 (20%) 72 (35%)
Complicating disease Yes 1 65 (25%) 60 (29%)
No 0 195 (75%) 148 (71%)
Sex Male 1 146 (56%) 98 (47%)
Female 0 114 (44%) 110 (53%)
Histological I I 11 (4%) 4 (2%)
differentiation II 2 163 (63%) 96 (46%)
III 3 86 (33%) 104 (50%)
IV 4 0 4 (2%)
Age (years) > 70a 1 92 (35%) 63 (30%)
<70 0 168 (65%) 145 (70%)
mean± 1 s.d. (range) 64.6±9.8 63.7±9.8
(29,80) (30,79)
Max. diameter (cm) 6.1±5.9 5.8±4.0
mean±l s.d.
aAltemative scoring: actual age minus 70 years if above 70; 0
otherwise.104 S.M. BENTZEN et al.
Patient's age
Age above 70 years had a detrimental effect on the loco-
regional control probability in patients with Dukes' B
tumours (Table III). There was no trend towards a gradual
worsening of the prognosis with increasing age below 70
years. The same picture was seen in the multivariate analysis
where age above 70 was also statistically significant (Table
IV). Using the number of years above 70 as a covariate in
the PHM analysis resulted in a poorer fit than simply group-
ing the patients in those below and above 70 years of age. In
patients with Dukes' C tumours age had no significant influ-
ence in predicting loco-regional outcome.
Localisation
The distance from the anal verge had a significant influence
on the time to loco-regional recurrence in both stages Dukes'
B and C where patients with higher situated tumours did
better than those with a less than 10 cm distance from the
anal verge (Table IV).
Tumour size
Univariate analyses showed a statistically significant im-
provement in loco-regional control with increasing tumour
size in Dukes' B tumours whereas no significant trend was
observed in the Dukes' C group (Table V). In the multi-
variate analyses (Table IV), the trend in Dukes' B patients
was still seen (P = 0.04) but in Dukes' C tumours maximum
tumour diameter turned out to be highly significant
(P = 0.0004) when allowing for other patient characteristics.
Note that the negative regression coefficient (p) in Table IV
means that the hazard of loco-regional recurrence is decreas-
ing with increasing tumour size.
Table III 5-year loco-regional control according to patients age
Dukes' B Dukes' C
Age years Control' No. pts. ControPb No. pts.
20-50 77.7±9.7% 22 62.6±8.9% 38
51-60 89.9±4.2% 51 59.0± 10.1% 36
61-70 89.4±3.0% 111 52.3±6.3% 90
71-80 71.6±5.8% 76 62.5±8.1% 44
20-70C 88.2±2.5% 184 -
aTest-for-trend: X2 = 2.6, P =0.11; Departure-from-trend: y2 = 5.6,
P= 0.06; bTest-for-trend: Xl = 0.1, P = 0.75; 'Tested vs 71 -80 years
group: log-rank test x2= 7.59, P = 0.006.
Resection ofother organs
The necessity to partially resect neighbouring organs was
relatively rare, about 10% in both Dukes' B and C tumours
(Table II). However, this was the strongest single deter-
minant of loco-regional control in patients with Dukes' C
tumours (Table IV). No significant effect of this covariate
could be demonstrated in Dukes' B cases.
Microscopic appearance
Perineural invasion had a highly significant and strongly
negative influence on loco-regional control probability in
both Dukes' stages (Table IV). While significant in Dukes' C
tumours, venous invasion had no significant influence on
loco-regional outcome in Dukes' B lesions. Histologic differ-
entiation was also tested but found to be insignificant in both
Dukes' stages.
Sex, CEA, and other characteristics
No other clinical characteristic had significant influence on
the time to loco-regional recurrence in the multivariate ana-
lysis. Sex, preoperative CEA, and number of tumours in the
rectum and the rectosigmoid were all tested but none of them
contributed significantly in describing the loco-regional out-
come. The only exception was complicating disease, that is
disease affecting the patients general condition that was unre-
lated to the cancer. In the analysis of Dukes' B tumours,
when entering parameters based on their improvement of the
global x2 of the model, this parameter was entered in the
model instead of the distance from the anal verge. As the
group of patients with complicating disease is more difficult
to characterise, the distance from the anal verge was prefer-
red as a prognosticator in the model.
Also a univariate analysis of preoperative CEA (Figure 2)
showed no significant importance of this parameter in either
of the two Dukes' stages with respect to prediction of loco-
regional outcome. The cutpoints used for pooling -the
patients were the median and the 75 percentile of the CEA
distribution of all Dukes' B and C patients taken together.
Prognosticforecasts
The PHM allows prognostic forecasts to be made in groups
or individual patients as discussed in some detail previously
(Bentzen et al., 1988b; Bentzen et al., 1988a; Bentzen et al.,
1990). Figure 3 shows the predicted loco-regional control vs
observation time in four hypothetical patients (Table VI).
These patients were selected to have characteristics associated
Table IV Final regression models
Covariate 3 s.d. exp(1) P-value"
Dukes' B
Perineural invasion 1.417 0.341 4.126 0.0000
Tumour localisation 1.158 0.331 3.495 0.0002
Age above 70 years 0.777 0.328 2.373 0.009
Max. diameter -0.140 0.081 0.869 0.043
Dukes' C
Resection other organs 0.812 0.336 2.415 0.03
Perineural invasion 0.714 0.251 2.041 0.002
Tumour localisation 0.473 0.251 1.884 0.03
Venous invasion 0.442 0.256 1.725 0.04
Max. diameter 0.069 0.021 1.071 0.0004
'One-sided.
Table V 5-year loco-regional control according to tumour size
Dukes' B Dukes' C
Max. diam. Controla No. pts. Control No. pts.
0-3 cm 67.9±7.8% 45 62.6± 8.9% 38
4cm 82.0±5.7% 48 59.0± 10.1% 36
5-7 cm 87.6± 3.2% 114 52.3± 6.3% 90
8 + cm 90.6±4.0% 53 62.5± 8.1% 44
'Test-for-trend: Xl = 5.7, P = 0.017. "Test-for-trend: x2= 1.0, P=
0.32.
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Figure 2 Lack of influence of preoperative CEA concentration
on the probability of loco-regional control. , 0-3.1 ngml-';
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Figure 3 Estimated loco-regional control vs observation time in
four hypothetical patients with Dukes' B or C tumours. The
clinicopathological characteristics of these four patients are given
in Table VI.
Table VI Loco-regional control forecasts
Dukes' B Goodprognosis: No perineural invasion, tumour located
more than 10cm from anal verge, <70 years of age,
tumour diameter 6 cm or more:
Estimated control at 5 years 95% or more.
Poor prognosis: Perineural invasion, tumour less than
10cm from anal verge, > 70 years of age, tumour
diameter 7 cm or less:
Estimated control at 5 years 27% or less.
Dukes' C Goodprognosis: No venous or perineural invasion, no
resection ofneighbourorgans, tumour located morethan
10 cm from anal verge, tumour diameter 5 cm or less:
Estimated control at 5 years 77% or more.
Poor prognosis: Perineural and venous invasion,
tumour located less than 10 cm from anal verge, with
resection of neighbour organs, irrespective of tumour
diameter:
Estimated control at 5 years 11% or less.
with a very low/high probability of loco-regional control
among patients with Dukes' B and C tumours. The good
prognostic cases are quite frequent as 19% and 17% of the
patients with Dukes' B and C tumours, respectively, are
estimated to have as good as or better prognosis than the
hypothetical 'best cases'. The two 'worst case' patients are
more extreme as only 3% (Dukes' B) and 1% (Dukes' C) of
the patients would have a similar or higher risk of loco-
regional recurrence.
Adjuvant radiotherapy in high-risk patients
Similar to our previous analysis of survival data in the same
series (Bentzen et al., 1988a), an effect of adjuvant post-
operative radiotherapy was specifically sought for in the
group of high-risk patients. All patients with Dukes' C
tumours were grouped into four categories according to the
quartiles of the distribution of relative hazard rates estimated
from the PHM analysis. In each of these four groups, the
loco-regional control was compared between patients ran-
domised to surgery alone as opposed to patients who were
randomised to receive adjuvant radiotherapy. Only in the
high-risk group, that is among the quarter of the patients
with the highest probability of developing a loco-regional
recurrence, was a significant difference seen in favour of
patients receiving radiotherapy (Table VII). The hazard rate
among patients treated with surgery alone was estimated to
be 2.4 (95% c.l. 1.1-5.3) times as high as that of patients
who received postoperative radiotherapy. None of the other
Table VII Effect ofadjuvant radiotherapy in high-risk patients with
Dukes' C tumours
Radio- Surgery Log-rank
therapy alone test
Loco-regional control at 40± 11% 25± 11% P = 0.03a
5 years
Median time to loco- 34 12
regional recurrence
(months)
Survival at 5 years 23±7% 0% P = 0.23
Median survival (months) 21 25
aWith the Gehan-Breslow test X? = 8.71, P = 0.003.
three groups showed any benefit for either of the two arms.
When grouped together the hazard rate among patients treat-
ed with surgery alone was estimated to be 0.8 (95% c.l.
0.5-1.5) times that of patients receiving adjuvant radio-
therapy, thus radiotherapy did not imply any increase or
reduction in the risk ofdeveloping a loco-regional recurrence
among these patients.
The apparent benefit from adjuvant radiotherapy in the
high-risk patients was not associated with a statistically
significantly improved survival: The 5 year survival rate was
higher among patients who received radiotherapy. However,
very few patients were still at risk after 3 years and the
median survival time in the two treatment arms was identical.
Discussion
Patients age
When survival was used as the endpoint a gradual worsening
of the prognosis was seen with increasing age in patients aged
more than 60 years (Bentzen et al., 1988a). The same pattern
was not seen with respect to loco-regional control, when the
control probability appeared to be independent of age up to
70 years and with a poorer prognosis beyond that age (Table
III). This is in agreement with multivariate survival analyses
(Bentzen et al., 1988a; Chapuis et al., 1985) but contrasts the
findings in a number ofunivariate analyses (Rich et al., 1983;
Block & Enker, 1971; Jensen et al., 1970). Probably, the
observed association between low malignancy grade and age
(Dukes & Bussey, 1958), corrected for in multivariate ana-
lyses, may have confounded the univariate analyses.
Localisation
A number of investigators (Bentzen et al., 1988a; Sugarbaker
et al., 1985) have noted that low situated tumours do worse
than those located at larger distances from the anal verge.
Probably, this is a consequence of both the difficulty in
obtaining a tumour-free lateral resection margin in the low
situated tumours (Quirke et al., 1986) and of the difference in
lymphatic drainage between these tumours and the higher
situated ones (Sugarbaker et al., 1985).
Tumour size
The prognostic significance of the size of the primary tumour
seems to be different in the two Dukes' stages analysed here
(Table IV). Large tumours presenting without lymph node
metastasis, that is large Dukes' B lesions, may have a less
aggressive natural history. Among patients with Dukes' C
tumours, the influence of tumour size is consistent with what
is seen in most other cancers: increasing tumour size is
associated with a decreasing probability of obtaining loco-
regional control.
Resection ofother organs
Even among patients judged to have completely resectable
tumours, 11% required resection ofneighbour organs in both
Dukes' stages (Table II). Despite the relatively low frequency106 S.M. BENTZEN et al.
of this characteristics, it was found to be associated with a
statistically significantly higher risk of developing a loco-
regional recurrence in patients with Dukes' C tumours.
Moreover, this was the strongest single risk factor with an
estimated hazard in a patient where resection of other organs
was necessary of 2.4 times as high as in a patient where this
was not the case, all other characteristics being equal.
In patients with Dukes' B tumours, resection of other
organs did not reach statistical significance in the PHM
analysis, neither when using loco-regional control as the
endpoint nor when looking at survival (Bentzen et al.,
1988a).
Microscopic appearance
Already Seefeld and Bargen (1943) observed an increased
rate of local recurrences in patients with perineural invasion.
Here, this was the single most important parameter in pre-
dicting loco-regional outcome in patients with Dukes' B
tumours and the second most important in patients with
Dukes' C tumours. In our previous analysis of survival data
(Bentzen et al., 1988a), perineural invasion was the strongest
prognosticator in both Dukes' stages.
Venous invasion was associated with an increased risk of
loco-regional recurrence in patients with Dukes' C tumours
(Table IV). In patients with Dukes' B tumours, venous
invasion, of borderline significance (P = 0.07) when using
survival as the endpoint, was not a significant factor in
predicting loco-regional outcome.
Histopathologic grading has no independent influence of
the time to loco-regional recurrence when other clinico-
pathological characteristics are allowed for in a multivariate
analysis.
Sex andpreoperative CEA
Elevated preoperative CEA was found by Wanebo et al.
(1978) to be significantly associated with disease-free survival.
Analysing the present series, using death with cancer as the
endpoint (Bentzen et al., 1988a), demonstrated the same
association in a multivariate analysis. However, the risk of
loco-regional recurrence was unaffected by the level of pre-
operative CEA. One possible explanation is that elevated
preoperative CEA could be associated with a higher risk of
occult distant metastasis. Direct testing of this hypothesis
awaits an anlaysis of data on distant relapses in the present
study.
The prognostic importance of sex has yet to be estimated.
One multivariate analysis (Chapuis et al., 1985) found a
significantly better survival rate in females than in males and
the authors proposed an influence of pregnancy and parity.
This result was not confirmed by Bentzen et al. (1988a)
although sex had a P-value of 0.07 in the Dukes' C group
when survival was used as the endpoint. However, in the
present analysis there was no significant association between,
sex and loco-regional outcome in either of the Dukes' stages.
Adjuvant post-operative radiotherapy
Censoring all observations at 1.5 or 2 years showed a signi-
ficant benefit with respect to loco-regional control after adju-
vant radiotherapy. However, when 5 years of follow-up was
available the temporary advantage of adjuvant radiotherapy
cancelled out (Table I). Therefore it is appropriate to warn
against premature analysis and reporting of loco-regional
control in patients with Dukes' C tumours. An early analysis
of the Danish Colorectal Cancer trial (Balslev et al., 1986)
found a statistically significantly reduced risk of local recur-
rence at 2 years; a reduction that was found to be insigni-
ficant when extending the observation time to 45 months
(I, = 2.67, P = 0.1). However, at that time only 12 and nine
patients were at risk at 45 months in the radiotherapy and
surgery-alone arms, respectively.
When looking at the results among the high-risk patients,
a significant reduction in loco-regional recurrence rate was
seen after postoperative radiotherapy. This was not a data-
generated hypothesis, but rather based on the a priori expec-
tation that radiotherapy would yield maximum benefit with
respect to loco-regional control in this specific group of
patients. The improved loco-regional control did not cause
any significant improvement in survival. It should be noted,
though, that the test-strength for detecting a clinically rele-
vant improvement in survival is low because of the limited
number of patients. Distant metastases constitute a serious
therapeutic problem in the same high-risk patients and the
potential gain from improved loco-regional control with
respect to survival is difficult to assess.
In the group with Dukes' B tumours there was no signi-
ficant benefit from radiotherapy in any of the risk-defined
subsets.
Other strategies for combined surgery and radiotherapy
have been suggested: preoperative radiotherapy or combined
pre- and postoperative (so-called sandwich) radiotherapy.
Although several trials, historically controlled or randomised
(see the review by Cohen et al., 1989 and Dahl et al., 1990),
have found an improved local control after combined surgery
and radiotherapy the actual importance, if any, of the
sequence of the two treatment modalities remains to be
investigated. Furthermore, in most of these trials the im-
provement in local control after preoperative radiotherpy did
not result in any significant improvement in survival (Mayer
et al., 1989; Cohen et al., 1989).
Designing trials ofintensified local treatment
The large variability in the natural history of colorectal
cancer, even within each Dukes' category, has some poten-
tially important implications for the design of randomised
trials of more effective loco-regional treatment in this disease.
About 15% of those patients with Dukes' C tumours, who
fulfilled the inclusion criteria for the CRES trial, has a
predicted 5-year loco-regional control rate of 30% or less
(Figure 4)*. These patients consititute a high-risk subset of
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Figure 4 About 15% of the patients with Dukes' C tumours
have an estimated 5-year loco-regional control rate of less than
30%. These patients have a predicted loco-regional control curve
falling within the hatched area. A hypothetical therapy controll-
ing 50% of the loco-regional recurrences seen after surgery alone
would improve the overall 5-year loco-regional control from 19%
to 59% (indicated by the arrow).
*This subgroup of patients with Dukes' C tumours is not readily
characterised by their clinico-pathological features. Technically, they
may be found as patients in whom the sum (over all relevant
characteristics) of the products of the PHM score (Table II) times
the regression coefficient (, in Table IV) is equal to or greater than
1.88. An example is the 'poor case' of Table VI.
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Dukes' C patients with an estimated 5-year control rate in
the group as a whole of only 19%. Obviously, these patients
would be candidates for a more effective adjuvant regional
treatment. At the other end of the scale there are groups of
Dukes' C patients with a very high probability of obtaining
loco-regional control. Inclusion of these low-risk patients in a
clinical trial would tend to dilute the possible benefit from a
more efficient experimental treatment. To illustrate this point,
assume that a novel therapy, say, a more intense
radiotherapy regimen, is being tested. The treatment is
expected to control half of the loco-regional recurrences seen
with the current therapies, that is the 5-year loco-regional
control rate among patients with resectable Dukes' C
tumours would increase from 67% to 83%. Even this rela-
tively effective hypothetical treatment would require quite a
large number of patients to be entered in a randomised trial.
Assuming that the proposed trial is open for patient intake in
3 years and that an additional follow-up period of 3 years is
added, then with a two-sided confidence level of 0.05 and a
power of the test of 90%, an accrual rate of 70 patients per
year is required. Now, assume that the relative efficacy of the
novel therapy is the same among the high-risk patients defin-
ed above, i.e. that half of the potential recurrences are con-
trolled by the new treatment regimen. Then, if the trial is
restricted to these patients, the control rate would increase
from 19% to 60% (Figure 4). A calculation shows that this
would reduce the accrual rate to only 23 patients per year,
that is a little less than one third of the number of patients
needed when applying the treatment to all Dukes' C patients.
Conclusion
Subgroups of patients with Dukes' B or C colorectal cancer
have been identified with a probability of loco-regional con-
trol that differs markedly from the average within the two
stages. Such variability may overshadow the potential benefit
of more aggressive loco-regional treatments. However, the
present study suggests that patients with Dukes' C tumours
and with a high risk of loco-regional recurrence may benefit
from postoperative radiotherapy. If this hypothesis is tested
in the group of patients assumed to have maximal benefit
from loco-regional treatment, a considerable decrease will
result in the number of patients needed as compared to a
trial testing radiotherapy among all Dukes' C patients.
Supported by the Danish Cancer Society.
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